In a recent article from The Motley Fool, it has highlighted the top stocks that should be on the radar of every IRA investors. According to Keith Speights, Facebook (NASDAQ: FB), International Business Machine (NYSE: IBM) and Jazz Pharmaceuticals (NASDAQ:JAZZ) could be the best stocks one should consider investing in for the month of August and the coming months. The three companies all reported to perform well this month with promising opportunities and predictions ahead of them.
The 3 Top Stocks for Your IRA in August
The truth is that regularly adding to your retirement accounts is a really smart way to achieve your long-term goals. Markets will go up, and they’ll go down, but time is on your side if you’ve got years to go before retirement.
Click here to read more
IRA holders investing in stocks are naturally wary of the stocks playing field. After all, as they say, nothing is constant — all the more in stock investing. Speights, nonetheless, stressed in his article that in this playing field, the future should be the paramount consideration.
FB, IBM and Jazz Pharma | Commitment, Growth, and Outstanding Metrics
IBM is an excellent option for dividend stocks investors. Speights described IBM’s current 4.13% dividend yield as “mouthwatering.” The tech company reportedly uses 47% of its earnings to fund its dividend program, running consistently to its 17-year continual dedication in raising its dividend.
Facebook’s stock performance this year revealed a staggering 50% growth, making it a good candidate for a growth stock investment. With its increasing users and the growing demand for mobile advertising, FB can definitely tread ahead the market strongly. Mobile is the future after all.
Jazz Pharmaceuticals, as Speights wrote, seems to be a very good value stock option with its good-looking PEG ratio of only 0.79 on top of its less than 12 times expected earnings stock trading.
The Future: Challenges, Predictions, and Foreseen Value
— BestBitz (@TheBestBitz) June 12, 2017
Despite IBM’s good dividend program, the company has been facing revenue decline for 21 consecutive quarters, affecting its stocks as a result, according to Speights. One need not worry if the main goal for investing is income. IBM will not disappoint with that.
Facebook, on the other hand, is predicted to keep its trajectory as Wall Street analysts report a projected average annual earnings growth of more than 27% over the coming years.
Lastly, in Jazz Pharma’s case, the company is expecting prosperous years with the recent regulatory approval of its drug Vyxeos. A drug for acute myeloid leukemia. Furthermore, Speights added Jazz’s scheduled approval application this year of its drug JZP-110 — a potential treatment for excessive sleepiness associated with obstructive sleep apnea and narcolepsy — as an added value for the company in the coming years.
Speights supported his list of top stocks to invest in this month with data and predictions. While numbers can give certainty, the stock market and the world of business is ever volatile. Can these companies keep their momentum in the coming years? Only time will tell.
If you want to learn more about stocks you can invest in for this year and the next, click on this video:
Which of these three stocks will you want to invest in? Let us know why in the comments section below!